{
    "id": 8145,
    "fullName": "EHMT2 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "EHMT2 over exp indicates an over expression of the Ehmt2 protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 10919,
        "geneSymbol": "EHMT2",
        "terms": [
            "EHMT2",
            "BAT8",
            "C6orf30",
            "G9A",
            "GAT8",
            "KMT1C",
            "NG36"
        ]
    },
    "variant": "over exp",
    "createDate": "06/23/2015",
    "updateDate": "11/29/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2467,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a human lung cancer cell line over expressing EHMT2 was sensitive to BIX-01294 as demonstrated by suppression of cell growth (PMID: 21847359).",
            "molecularProfile": {
                "id": 8035,
                "profileName": "EHMT2 over exp"
            },
            "therapy": {
                "id": 2862,
                "therapyName": "BIX-01294",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3123,
                    "pubMedId": 21847359,
                    "title": "Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21847359"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2466,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a human bladder cancer cell line over expressing EHMT2 was sensitive to BIX-01294 as demonstrated by suppression of cell growth (PMID: 21847359).",
            "molecularProfile": {
                "id": 8035,
                "profileName": "EHMT2 over exp"
            },
            "therapy": {
                "id": 2862,
                "therapyName": "BIX-01294",
                "synonyms": null
            },
            "indication": {
                "id": 4007,
                "name": "bladder carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3123,
                    "pubMedId": 21847359,
                    "title": "Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21847359"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 8035,
            "profileName": "EHMT2 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}